Invitation-only investment pitching events for deep tech chemistry ventures
Investment Catalyst (IC) is a series of invitation-only investment pitching events for chemistry ventures developing technology aiming to transform health, energy, environment, enabling technologies and many more. Since 2017, the Royal Society of Chemistry in partnership with the UK Business Angels Association ran 10 events, which facilitated 75 investment-ready ventures (IC ventures) to pitch to a carefully selected pool of investors. After a break due to the Covid pandemic, we're excited that the Investment Catalyst is back as an in-person event, in London.
VisusNano is developing a drug-eluting intraocular lens for use in patients undergoing cataract surgery, the most common procedure worldwide. By improving patient outcomes, their technology has the potential to revolutionise cataract surgery in both the human and veterinary markets.
Drug discovery is an extremely slow process, which requires testing of hundreds of compounds to find the most promising candidate. The HexagonFab sensor system is 10x faster than existing methods. It will transform R&D in the pharmaceutical industry, increasing speed and decreasing risk.
Somnus is end-user led with a team that is deeply rooted in clinical care and research-led innovations. Their technology satisfies an unmet need and their scalable solution will facilitate the safer adoption of intravenous anaesthesia throughout the world. Thus allowing more patients to benefit from superior propofol-based anaesthesia instead of gases.
What goes in the oceans eventually arrives on our plates. Plastic microbeads used in cosmetics, paints and coating, and many other applications pollute the oceans and are an environmental and health hazard. Naturbeads is scaling up a technology to produce biodegradable cellulose beads to replace polluting plastic microbeads.
FluoretiQ have developed a NANOPLEX platform to reduce the time to correctly diagnose bacterial infections from 2 days to 15 minutes. NANOPLEX has a total market potential of £1bn spread across infectious disease testing, meat and poultry testing and oncology.
Glaia’s disruptive product boosts crop yields sustainably. Based on a water-soluble, sugar-derived nanomaterial that unlocks the current bottleneck in agricultural productivity: photosynthesis. Glaia’s unique technology enhances the photosynthetic efficiency of crops, leading to increased yields of 20-40% while decreasing the emissions from crop production.
Our Pitching event for deep tech chemistry ventures kicks off on 28 February 2023. This edition of the Investment Catalyst will feature nine investment ready ventures collectively pitching for over £40 million investment. The businesses cover deep tech chemistry for:
Burlington House Piccadilly, London, W1J 0BA
Our investor networking events are by invite only. If you're interested in being invited to this and future events, please register your interest to join this community now.
Joining our investor network
Our Pitching event for deep tech chemistry ventures kicks off on 14 November 2023. This edition of the Investment Catalyst will feature nine investment ready ventures collectively pitching for over £40 million investment. The businesses cover deep tech chemistry for:
pitched at the IC since 2017
by IC ventures since 2017
by IC ventures in 2022
by one IC venture
Find out more about the Investment Catalyst.